Advertise
NEWSLETTER
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Free to view
Jim Mellon, chair and founder of Juvenescence

The Big Picture: Covid-19 and Longevity investing

Video interview: talking senescence with Nina Khera

David Wood

Exclusive video interview: David Wood demystifies the transhumanist agenda

As Longevity moves quickly into the mainstream there are terms and legacies that some use to

Video interview with BioViva’s Liz Parrish

Video interview with Dr Isabelle Schiffer on senolytic safety

Alon Braun, Neurotech founder

Neurotech is the new blue ocean

er $0.5bn cumulative investment, Human Longevity Inc. pivots into high-end medical services to seek scale and ROI. An exclusive LongevityTV interview.

Exclusive video interview: Human Longevity Inc.’s Chairman

A popular talk on Longevity 2020 was from Steve Perry who shared his experience as the first of 200+ patients who have experimented with GDF11

Results of exogenous GDF11 supplementation – the view of Patient Zero

5 investment lessons from coronavirus

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed